Jobs
Associate Director – Trade Compliance & Import-Export Services, Foreign-Trade Zone Operations, Lilly Research Laboratories
Associate Director – Trade Compliance & Import-Export Services, Foreign-Trade Zone Operations, Lilly Research Laboratories
US, Indianapolis IN
·
On-site
·
Full-time
·
2d ago
About Eli Lilly
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
About Eli Lilly
Eli Lilly
PublicEli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
10,001+
Employees
US
Headquarters
$588B
Valuation
Reviews
3.8
10 reviews
Work-life balance
3.2
Compensation
4.1
Culture
3.7
Career
2.8
Management
3.9
72%
Recommend to a friend
Pros
Excellent compensation and benefits
Supportive management and leadership
Flexible work arrangements
Cons
Limited career advancement opportunities
High stress and demanding workload
Fast-paced and high-pressure environment
Salary Ranges
56 data points
Mid/L4
Senior/L5
Mid/L4 · ADVISOR - BRD ANALYTICAL DEVELOPMENT
2 reports
$188,000
total per year
Base
$145,411
Stock
-
Bonus
-
$188,000
$188,000
Interview experience
2 interviews
Difficulty
2.5
/ 5
Duration
14-28 weeks
Offer rate
100%
Experience
Positive 50%
Neutral 50%
Negative 0%
Interview process
1
Application Review
2
HR Screen
3
Phone/Video Interview
4
Hiring Manager Interview
5
Final Interview/Panel
6
Offer
Common questions
Behavioral/STAR
Past Experience
Culture Fit
Industry Knowledge
Technical Knowledge
News & Buzz
Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 (NYSE:LLY) - Seeking Alpha
Seeking Alpha
News
·
2d ago
Why Eli Lilly (LLY) Shares Are Trading Lower Today - StockStory
StockStory
News
·
2d ago
A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B - statnews.com
statnews.com
News
·
2d ago
Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters
Reuters
News
·
2d ago